A Motion-Activated Video Game for Prevention of Substance Use Disorder Relapse in Youth: Pilot Randomized Controlled Trial.

addiction treatment marijuana opioid technology video game youth

Journal

JMIR serious games
ISSN: 2291-9279
Titre abrégé: JMIR Serious Games
Pays: Canada
ID NLM: 101645255

Informations de publication

Date de publication:
23 May 2019
Historique:
received: 27 07 2018
accepted: 30 01 2019
revised: 29 01 2019
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 28 5 2019
Statut: epublish

Résumé

Body motion-activated video games are a promising strategy for promoting engagement in and adherence to addiction treatment among youth. This pilot randomized trial (N=80) investigated the feasibility of a body motion-activated video game prototype, Recovery Warrior 2.0, targeting relapse prevention in the context of a community inpatient care program for youth. Participants aged 15-25 years were recruited from an inpatient drug treatment program and randomized to receive treatment as usual (control) or game play with treatment as usual (intervention). Assessments were conducted at baseline, prior to discharge, and at 4 and 8 weeks postdischarge. The provision of the game play intervention was found to be feasible in the inpatient setting. On an average, participants in the intervention group played for 36.6 minutes and on 3.6 different days. Participants in the intervention group mostly agreed that they would use the refusal skills taught by the game. Participants in the intervention group reported attending more outpatient counseling sessions than those in the control group (10.8 versus 4.8), but the difference was not significant (P=.32). The game had no effect on drug use at 4 or 8 weeks postdischarge, with the exception of a benefit reported at the 4-week follow-up among participants receiving treatment for marijuana addiction (P=.04). Preliminary evidence indicates that a motion-activated video game for addiction recovery appears to be feasible and acceptable for youth within the context of inpatient treatment, but not outpatient treatment. With further development, such games hold promise as a tool for the treatment of youth substance use disorder. ClinicalTrials.gov NCT03957798; https://clinicaltrials.gov/show/NCT03957798 (Archived by WebCite at http://www.webcitation.org/78XU6ENB4).

Sections du résumé

BACKGROUND BACKGROUND
Body motion-activated video games are a promising strategy for promoting engagement in and adherence to addiction treatment among youth.
OBJECTIVE OBJECTIVE
This pilot randomized trial (N=80) investigated the feasibility of a body motion-activated video game prototype, Recovery Warrior 2.0, targeting relapse prevention in the context of a community inpatient care program for youth.
METHODS METHODS
Participants aged 15-25 years were recruited from an inpatient drug treatment program and randomized to receive treatment as usual (control) or game play with treatment as usual (intervention). Assessments were conducted at baseline, prior to discharge, and at 4 and 8 weeks postdischarge.
RESULTS RESULTS
The provision of the game play intervention was found to be feasible in the inpatient setting. On an average, participants in the intervention group played for 36.6 minutes and on 3.6 different days. Participants in the intervention group mostly agreed that they would use the refusal skills taught by the game. Participants in the intervention group reported attending more outpatient counseling sessions than those in the control group (10.8 versus 4.8), but the difference was not significant (P=.32). The game had no effect on drug use at 4 or 8 weeks postdischarge, with the exception of a benefit reported at the 4-week follow-up among participants receiving treatment for marijuana addiction (P=.04).
CONCLUSIONS CONCLUSIONS
Preliminary evidence indicates that a motion-activated video game for addiction recovery appears to be feasible and acceptable for youth within the context of inpatient treatment, but not outpatient treatment. With further development, such games hold promise as a tool for the treatment of youth substance use disorder.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT03957798; https://clinicaltrials.gov/show/NCT03957798 (Archived by WebCite at http://www.webcitation.org/78XU6ENB4).

Identifiants

pubmed: 31124471
pii: v7i2e11716
doi: 10.2196/11716
pmc: PMC6552452
doi:

Banques de données

ClinicalTrials.gov
['NCT03957798']

Types de publication

Journal Article

Langues

eng

Pagination

e11716

Subventions

Organisme : NIDA NIH HHS
ID : HHSN271201300006C
Pays : United States

Informations de copyright

©Lorien C Abroms, Marc Fishman, Hoa Vo, Shawn C Chiang, Victoria Somerville, Lawrence Rakhmanov, Michael Ruggiero, Daniel Greenberg. Originally published in JMIR Serious Games (http://games.jmir.org), 23.05.2019.

Références

Alcohol Clin Exp Res. 1999 Aug;23(8):1289-95
pubmed: 10470970
Trends Cogn Sci. 2006 Jan;10(1):14-23
pubmed: 16321563
J Prev Interv Community. 2005;29(1-2):117-30
pubmed: 16804562
J Psychoactive Drugs. 2008 Mar;40(1):55-65
pubmed: 18472665
JAMA. 2008 Nov 5;300(17):2003-11
pubmed: 18984887
Drug Alcohol Depend. 2009 Apr 1;101(1-2):13-9
pubmed: 19081205
Curr Psychiatry Rep. 2009 Oct;11(5):360-3
pubmed: 19785976
Cyberpsychol Behav. 2009 Oct;12(5):477-83
pubmed: 19817561
J Addict Dis. 2011 Jan;30(1):17-26
pubmed: 21218307
J Appl Commun Res. 2011;39(2):103-122
pubmed: 21552345
CBE Life Sci Educ. 2012 Spring;11(1):94-102
pubmed: 22383621
Am J Prev Med. 2012 Jun;42(6):630-8
pubmed: 22608382
Psychiatr Clin North Am. 2012 Jun;35(2):481-93
pubmed: 22640767
PLoS One. 2013 Jun 14;8(6):e65351
pubmed: 23799008
J Psychiatr Ment Health Nurs. 2013 Oct;20(8):752-60
pubmed: 23964592
Drug Alcohol Rev. 2014 Mar;33(2):129-35
pubmed: 24329810
Games Health J. 2015 Dec;4(6):494-501
pubmed: 26213838
J Behav Ther Exp Psychiatry. 1988 Sep;19(3):171-9
pubmed: 3069874

Auteurs

Lorien C Abroms (LC)

Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States.

Marc Fishman (M)

Mountain Manor Treatment Center, Baltimore, MD, United States.

Hoa Vo (H)

Mountain Manor Treatment Center, Baltimore, MD, United States.

Shawn C Chiang (SC)

Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States.

Victoria Somerville (V)

Department of Prevention and Community Health, Milken Institute School of Public Health, The George Washington University, Washington, DC, United States.

Lawrence Rakhmanov (L)

Mountain Manor Treatment Center, Baltimore, MD, United States.

Michael Ruggiero (M)

Mountain Manor Treatment Center, Baltimore, MD, United States.

Daniel Greenberg (D)

Media Rez LLC, Washington, DC, United States.

Classifications MeSH